US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

RenovoRx Inc

0.8557

+0.105714.09%

Volume:547.40K

Turnover:453.40K

Market Cap:31.36M

PE:-2.37

High:0.8581

Open:0.7700

Low:0.7700

Close:0.7500

52wk High:1.69

52wk Low:0.7006

Shares:36.65M

Float Shares:30.09M

Volume Ratio:1.49

T/O Rate:1.82%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3612

EPS(LYR):-0.3958

ROE:-107.11%

ROA:-54.82%

PB:2.95

PE(LYR):-2.16

Loading ...

Overview Company News Filings

RenovoRx Inc publishes investor presentation highlighting RenovoCath commercialization and cancer therapy platform

RenovoRx announces first patient procedure completed in PanTheR study

RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th

RenovoRx Inc. Unveils Investor Presentation Highlighting TAMP Therapy Platform and Progress in Pancreatic Cancer Treatment

RenovoRx Inc. Unveils Investor Presentation Highlighting Innovative Cancer Treatment Platform and Commercial Progress

RenovoRx Is Maintained at Buy by Ascendiant Capital

Shaun Bagai, CEO, Reports Acquisition of RenovoRx Inc. Common Shares

RenovoRx Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $422.00K Beat $329.67K Estimate

RenovoRx Inc. Reports Q2 2025 Revenue of Over $400,000, Marking Significant Commercial Growth for RenovoCath Device

BRIEF-RenovoRx Q2 Net Income USD -2.895 Million

RenovoRx Inc. Expands Tumor Treatment Innovation with New Patent for TAMP Therapy Platform

RenovoRx Q2 Basic EPS USD -0.08

THOMSON REUTERS

RenovoRx Inc expected to post a loss of 8 cents a share - Earnings Preview

RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire

RenovoRx Inc. Launches PanTheR Post-Marketing Registry Study to Evaluate RenovoCath's Effectiveness in Treating Solid Tumors

RenovoRx Inc. Announces Second Quarter 2025 Financial Results Release

RenovoRx Inc. Conducted Annual Stockholders Meeting

Ramtin Agah, Chief Medical Officer, Reports Acquisition of RenovoRx Inc. Common Shares

RenovoRx Is Maintained at Buy by Ascendiant Capital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNXT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNXT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNXT\",,,,,undefined,":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":0.8557,"timestamp":1763404442688,"preClose":0.75,"halted":0,"volume":547404,"delay":0,"floatShares":30093240,"shares":36645884,"eps":-0.361218,"marketStatus":"Trading","change":0.1057,"latestTime":"11-17 13:34:08 EST","open":0.77,"high":0.8581,"low":0.77,"amount":453404.84708376,"amplitude":0.117467,"askPrice":0.8626,"askSize":100,"bidPrice":0.8411,"bidSize":500,"shortable":0,"etf":0,"ttmEps":-0.361218,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1763413200000},"marketStatusCode":2,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":0.75,"preHourTrading":{"tag":"盘前","latestPrice":0.739,"preClose":0.75,"latestTime":"09:25 EST","volume":16048,"amount":12464.05729088,"timestamp":1763389546225},"postHourTrading":{"tag":"盘后","latestPrice":0.7971,"preClose":0.75,"latestTime":"19:36 EST","volume":1268,"amount":999.8153,"timestamp":1763166991805},"volumeRatio":1.489759},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNXT\",,,,,undefined,":{"symbol":"RNXT","floatShares":30093240,"roa":"-54.82%","roe":"-107.11%","lyrEps":-0.395758,"volumeRatio":1.489759,"shares":36645884,"dividePrice":0,"high":0.8581,"amplitude":0.117467,"preClose":0.75,"low":0.77,"week52Low":0.7006,"pbRate":"2.95","psRate":"47.37","week52High":1.6899,"institutionHeld":0,"latestPrice":0.8557,"committee":0.666667,"eps":-0.361218,"divideRate":0,"volume":547404,"delay":0,"ttmEps":-0.361218,"open":0.77,"prevYearClose":1.29,"prevWeekClose":0.75,"prevMonthClose":1.11,"prevQuarterClose":1.27,"fiveDayClose":0.9962,"twentyDayClose":1.2,"sixtyDayClose":0.9403},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNXT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"RNXT","fiscalQuarterEnding":"2025/09","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2025-08-14","symbol":"RNXT","fiscalQuarterEnding":"2025/06","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2025-05-15","symbol":"RNXT","fiscalQuarterEnding":"2025/03","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-0.08},{"date":"2025-04-01","symbol":"RNXT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743494400000,"name":null,"time":"Pre-Market","dateTimestamp":1743480000000,"actualEps":null},{"date":"2024-11-14","symbol":"RNXT","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1731574800000,"name":null,"time":"Pre-Market","dateTimestamp":1731560400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNXT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNXT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1743224400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNXT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNXT","date":"2025-11-14","current":-2.36893,"percent":0.417466,"low":-30.306305,"twenty":-4.571628,"median":-3.043553,"eighty":-2.007002,"high":-0.700344,"avg":-4.081891,"sd":3.693588,"marketCap":35707749},"quantilePoints":[{"date":"2021-08-13","current":-24.2365,"twenty":-25.044383,"median":-24.2365,"eighty":-24.2365,"marketCap":94401168},{"date":"2021-08-20","current":-21.299903,"twenty":-24.2365,"median":-24.2365,"eighty":-23.061861,"marketCap":94401168},{"date":"2021-08-27","current":-14.585618,"twenty":-24.2365,"median":-23.229503,"eighty":-21.299903,"marketCap":64643461},{"date":"2021-09-03","current":-14.926139,"twenty":-24.2365,"median":-22.222505,"eighty":-17.003313,"marketCap":66152647},{"date":"2021-09-10","current":-17.707054,"twenty":-24.2365,"median":-21.299903,"eighty":-17.570846,"marketCap":78477665},{"date":"2021-09-17","current":-14.358605,"twenty":-24.2365,"median":-18.86104,"eighty":-15.255308,"marketCap":63637337},{"date":"2021-09-24","current":-13.270832,"twenty":-24.2365,"median":-18.312424,"eighty":-14.44941,"marketCap":58816327},{"date":"2021-10-01","current":-11.180416,"twenty":-23.430902,"median":-16.88413,"eighty":-13.893227,"marketCap":49551603},{"date":"2021-10-08","current":-10.80206,"twenty":-22.222505,"median":-15.266659,"eighty":-12.708973,"marketCap":47874729},{"date":"2021-10-15","current":-11.31284,"twenty":-22.222505,"median":-15.049104,"eighty":-11.358243,"marketCap":50138508},{"date":"2021-10-22","current":-11.123662,"twenty":-21.853464,"median":-14.358605,"eighty":-11.210684,"marketCap":49300072},{"date":"2021-10-29","current":-9.799417,"twenty":-21.299903,"median":-13.923496,"eighty":-11.123662,"marketCap":43431015},{"date":"2021-11-05","current":-9.950759,"twenty":-20.339492,"median":-13.734318,"eighty":-10.809627,"marketCap":44101765},{"date":"2021-11-12","current":-15.418001,"twenty":-18.868607,"median":-13.809989,"eighty":-10.733956,"marketCap":68332582},{"date":"2021-11-19","current":-12.111555,"twenty":-18.664295,"median":-13.280291,"eighty":-10.809627,"marketCap":58704708},{"date":"2021-11-26","current":-11.743798,"twenty":-18.40323,"median":-12.901839,"eighty":-10.851246,"marketCap":56922187},{"date":"2021-12-03","current":-11.854254,"twenty":-18.19135,"median":-12.920217,"eighty":-11.002588,"marketCap":57457567},{"date":"2021-12-10","current":-10.78829,"twenty":-17.661651,"median":-12.442372,"eighty":-10.851198,"marketCap":52290840},{"date":"2021-12-17","current":-10.108278,"twenty":-17.241677,"median":-12.137848,"eighty":-10.650719,"marketCap":48994825},{"date":"2021-12-23","current":-9.354752,"twenty":-16.28822,"median":-11.835875,"eighty":-10.457473,"marketCap":45342483},{"date":"2021-12-31","current":-8.895285,"twenty":-16.080124,"median":-11.780739,"eighty":-10.29128,"marketCap":43115446},{"date":"2022-01-07","current":-7.406611,"twenty":-16.061206,"median":-11.68912,"eighty":-10.102102,"marketCap":35899844},{"date":"2022-01-14","current":-7.461747,"twenty":-15.436919,"median":-11.369594,"eighty":-9.924491,"marketCap":36167089},{"date":"2022-01-21","current":-6.616328,"twenty":-15.421785,"median":-11.31284,"eighty":-9.619405,"marketCap":32069340},{"date":"2022-01-28","current":-5.734151,"twenty":-15.296927,"median":-11.180416,"eighty":-9.185668,"marketCap":27793428},{"date":"2022-02-04","current":-6.267132,"twenty":-15.251525,"median":-11.137485,"eighty":-8.891609,"marketCap":30376791},{"date":"2022-02-11","current":-6.781736,"twenty":-15.187204,"median":-11.123662,"eighty":-7.991054,"marketCap":32871073},{"date":"2022-02-18","current":-6.616328,"twenty":-14.975325,"median":-10.97232,"eighty":-7.564668,"marketCap":32069340},{"date":"2022-02-25","current":-6.193618,"twenty":-14.858389,"median":-10.820978,"eighty":-7.391908,"marketCap":30020465},{"date":"2022-03-04","current":-5.899559,"twenty":-14.67666,"median":-10.738422,"eighty":-7.094174,"marketCap":28595161},{"date":"2022-03-11","current":-5.789287,"twenty":-14.44941,"median":-10.593964,"eighty":-6.700869,"marketCap":28060672},{"date":"2022-03-18","current":-5.697393,"twenty":-14.256449,"median":-10.43113,"eighty":-6.616328,"marketCap":27615265},{"date":"2022-03-25","current":-5.917937,"twenty":-14.040786,"median":-10.329115,"eighty":-6.436216,"marketCap":28684243},{"date":"2022-04-01","current":-4.09774,"twenty":-13.919712,"median":-10.253444,"eighty":-6.259781,"marketCap":25914105},{"date":"2022-04-08","current":-4.040628,"twenty":-13.893227,"median":-10.102102,"eighty":-6.175239,"marketCap":25552933},{"date":"2022-04-14","current":-3.69796,"twenty":-13.825123,"median":-9.950759,"eighty":-6.109076,"marketCap":23385899},{"date":"2022-04-22","current":-2.669956,"twenty":-13.599816,"median":-9.861954,"eighty":-5.939991,"marketCap":16884800},{"date":"2022-04-29","current":-2.386195,"twenty":-13.350954,"median":-9.685568,"eighty":-5.840747,"marketCap":15090295},{"date":"2022-05-06","current":-2.52908,"twenty":-13.276507,"median":-9.299616,"eighty":-5.653284,"marketCap":15993905},{"date":"2022-05-13","current":-2.017568,"twenty":-13.167344,"median":-9.09745,"eighty":-5.583445,"marketCap":16501690},{"date":"2022-05-20","current":-2.039739,"twenty":-12.982705,"median":-8.950513,"eighty":-5.429065,"marketCap":16683027},{"date":"2022-05-27","current":-2.194937,"twenty":-12.923893,"median":-8.674741,"eighty":-4.243374,"marketCap":17952388},{"date":"2022-06-03","current":-2.128424,"twenty":-12.854054,"median":-8.013108,"eighty":-4.126295,"marketCap":17408376},{"date":"2022-06-10","current":-2.139509,"twenty":-12.618807,"median":-7.737427,"eighty":-3.994939,"marketCap":17499045},{"date":"2022-06-17","current":-2.217108,"twenty":-12.420778,"median":-7.535262,"eighty":-3.515204,"marketCap":18133726},{"date":"2022-06-24","current":-2.316878,"twenty":-12.334401,"median":-7.406611,"eighty":-2.729121,"marketCap":18949743},{"date":"2022-07-01","current":-2.217108,"twenty":-12.164141,"median":-7.214094,"eighty":-2.52908,"marketCap":18133726},{"date":"2022-07-08","current":-2.26145,"twenty":-12.122072,"median":-7.094174,"eighty":-2.465843,"marketCap":18496400},{"date":"2022-07-15","current":-2.150595,"twenty":-11.905714,"median":-6.781736,"eighty":-2.350482,"marketCap":17589714},{"date":"2022-07-22","current":-2.158576,"twenty":-11.824848,"median":-6.662274,"eighty":-2.316453,"marketCap":17654995},{"date":"2022-07-29","current":-2.155583,"twenty":-11.78809,"median":-6.616328,"eighty":-2.281404,"marketCap":17630515},{"date":"2022-08-05","current":-2.245819,"twenty":-11.780739,"median":-6.556597,"eighty":-2.26145,"marketCap":18368557},{"date":"2022-08-12","current":-2.256416,"twenty":-11.780739,"median":-6.30389,"eighty":-2.26145,"marketCap":21352462},{"date":"2022-08-19","current":-1.964184,"twenty":-11.751186,"median":-6.276321,"eighty":-2.260443,"marketCap":18587069},{"date":"2022-08-26","current":-2.108,"twenty":-11.656314,"median":-6.211996,"eighty":-2.225976,"marketCap":19948005},{"date":"2022-09-02","current":-2.155811,"twenty":-11.467966,"median":-6.175239,"eighty":-2.217108,"marketCap":20400441},{"date":"2022-09-09","current":-2.673206,"twenty":-11.392295,"median":-6.129293,"eighty":-2.217108,"marketCap":25296547},{"date":"2022-09-16","current":-2.337857,"twenty":-11.335542,"median":-6.101724,"eighty":-2.217108,"marketCap":22123145},{"date":"2022-09-23","current":-1.758184,"twenty":-11.31284,"median":-5.945505,"eighty":-2.217108,"marketCap":16637693},{"date":"2022-09-30","current":-1.935439,"twenty":-11.278788,"median":-5.899559,"eighty":-2.211541,"marketCap":18315063},{"date":"2022-10-07","current":-1.906695,"twenty":-11.210684,"median":-5.807665,"eighty":-2.194937,"marketCap":18043057},{"date":"2022-10-14","current":-1.647998,"twenty":-11.180416,"median":-5.697393,"eighty":-2.176091,"marketCap":15595004},{"date":"2022-10-21","current":-1.667161,"twenty":-11.165684,"median":-5.6055,"eighty":-2.16168,"marketCap":15776341},{"date":"2022-10-28","current":-1.686323,"twenty":-11.144836,"median":-5.568742,"eighty":-2.1576,"marketCap":15957678},{"date":"2022-11-04","current":-1.772556,"twenty":-11.129191,"median":-5.476849,"eighty":-2.15572,"marketCap":16773696},{"date":"2022-11-11","current":-1.8013,"twenty":-11.123662,"median":-5.421713,"eighty":-2.146161,"marketCap":17045702},{"date":"2022-11-18","current":-1.704466,"twenty":-11.123662,"median":-4.247657,"eighty":-2.128424,"marketCap":17194654},{"date":"2022-11-25","current":-1.630786,"twenty":-11.123662,"median":-4.183407,"eighty":-2.102251,"marketCap":16451372},{"date":"2022-12-02","current":-1.695448,"twenty":-11.063125,"median":-4.09774,"eighty":-2.076152,"marketCap":17103677},{"date":"2022-12-09","current":-1.749558,"twenty":-10.972223,"median":-4.012073,"eighty":-2.044565,"marketCap":17649539},{"date":"2022-12-16","current":-1.975016,"twenty":-10.911637,"median":-3.712238,"eighty":-2.028843,"marketCap":19923965},{"date":"2022-12-23","current":-1.776613,"twenty":-10.813411,"median":-3.43382,"eighty":-2.017568,"marketCap":17922470},{"date":"2022-12-30","current":-2.11931,"twenty":-10.799306,"median":-2.965657,"eighty":-2.007604,"marketCap":21379597},{"date":"2023-01-06","current":-2.723539,"twenty":-10.78829,"median":-2.789053,"eighty":-2.01209,"marketCap":27475057},{"date":"2023-01-13","current":-2.71452,"twenty":-10.688553,"median":-2.729121,"eighty":-2.017568,"marketCap":27384080},{"date":"2023-01-20","current":-2.93096,"twenty":-10.650719,"median":-2.858814,"eighty":-2.017568,"marketCap":29567528},{"date":"2023-01-27","current":-2.38986,"twenty":-10.603423,"median":-2.72633,"eighty":-2.017568,"marketCap":24108907},{"date":"2023-02-03","current":-2.795685,"twenty":-10.503158,"median":-2.723539,"eighty":-2.020851,"marketCap":28202873},{"date":"2023-02-10","current":-3.435987,"twenty":-10.46207,"median":-2.762403,"eighty":-2.027258,"marketCap":34662240},{"date":"2023-02-17","current":-3.697519,"twenty":-10.415323,"median":-2.848984,"eighty":-2.029032,"marketCap":37300574},{"date":"2023-02-24","current":-3.381877,"twenty":-10.370734,"median":-2.904411,"eighty":-2.035494,"marketCap":34116378},{"date":"2023-03-03","current":-4.783906,"twenty":-10.336682,"median":-2.983441,"eighty":-2.039739,"marketCap":47308045},{"date":"2023-03-10","current":-3.983522,"twenty":-10.306414,"median":-3.291694,"eighty":-2.040397,"marketCap":39393045},{"date":"2023-03-17","current":-2.870344,"twenty":-10.279929,"median":-3.273658,"eighty":-2.04643,"marketCap":28384827},{"date":"2023-03-24","current":-2.424152,"twenty":-10.24966,"median":-3.026902,"eighty":-2.060536,"marketCap":23972442},{"date":"2023-03-31","current":-3.206137,"twenty":-10.158777,"median":-3.05902,"eighty":-2.070779,"marketCap":31705487},{"date":"2023-04-06","current":-2.714766,"twenty":-10.105808,"median":-3.026821,"eighty":-2.072996,"marketCap":26846321},{"date":"2023-04-14","current":-2.457093,"twenty":-10.08987,"median":-2.93096,"eighty":-2.076152,"marketCap":24298196},{"date":"2023-04-21","current":-2.806792,"twenty":-10.023216,"median":-2.901614,"eighty":-2.082163,"marketCap":27756366},{"date":"2023-04-28","current":-2.862008,"twenty":-9.950759,"median":-2.862008,"eighty":-2.085945,"marketCap":28302393},{"date":"2023-05-05","current":-2.687158,"twenty":-9.940252,"median":-2.860411,"eighty":-2.092613,"marketCap":26573308},{"date":"2023-05-12","current":-2.383473,"twenty":-9.899476,"median":-2.850464,"eighty":-2.100335,"marketCap":23570160},{"date":"2023-05-19","current":-2.147625,"twenty":-9.795633,"median":-2.806792,"eighty":-2.097749,"marketCap":21783365},{"date":"2023-05-26","current":-1.897902,"twenty":-9.761513,"median":-2.787545,"eighty":-2.081524,"marketCap":19250416},{"date":"2023-06-02","current":-2.10767,"twenty":-9.685568,"median":-2.751161,"eighty":-2.072996,"marketCap":21378093},{"date":"2023-06-09","current":-1.94475,"twenty":-9.487078,"median":-2.741546,"eighty":-2.04643,"marketCap":19725597},{"date":"2023-06-16","current":-2.237526,"twenty":-9.32167,"median":-2.72633,"eighty":-2.035494,"marketCap":22695227},{"date":"2023-06-23","current":-2.027758,"twenty":-9.299616,"median":-2.723539,"eighty":-2.028748,"marketCap":20567549},{"date":"2023-06-29","current":-2.237526,"twenty":-9.299616,"median":-2.714766,"eighty":-2.028296,"marketCap":22695227},{"date":"2023-07-07","current":-2.027758,"twenty":-9.262859,"median":-2.713947,"eighty":-2.028116,"marketCap":20567549},{"date":"2023-07-14","current":-2.287471,"twenty":-9.163614,"median":-2.691821,"eighty":-2.027758,"marketCap":23201817},{"date":"2023-07-21","current":-2.157614,"twenty":-9.075396,"median":-2.677956,"eighty":-2.028116,"marketCap":21884683},{"date":"2023-07-28","current":-1.907891,"twenty":-9.027685,"median":-2.668951,"eighty":-2.027758,"marketCap":19351734},{"date":"2023-08-04","current":-1.987802,"twenty":-8.961559,"median":-2.62274,"eighty":-2.017568,"marketCap":20162278},{"date":"2023-08-11","current":-2.037747,"twenty":-8.887933,"median":-2.586451,"eighty":-2.017568,"marketCap":20668867},{"date":"2023-08-18","current":-1.887658,"twenty":-8.79604,"median":-2.56076,"eighty":-2.00778,"marketCap":18642508},{"date":"2023-08-25","current":-1.862302,"twenty":-8.630632,"median":-2.554924,"eighty":-1.997747,"marketCap":18392097},{"date":"2023-09-01","current":-1.754029,"twenty":-8.343925,"median":-2.534153,"eighty":-1.981809,"marketCap":17322789},{"date":"2023-09-08","current":-1.624101,"twenty":-7.991054,"median":-2.52908,"eighty":-1.977813,"marketCap":16039620},{"date":"2023-09-15","current":-1.634928,"twenty":-7.877106,"median":-2.524344,"eighty":-1.960635,"marketCap":16146550},{"date":"2023-09-22","current":-1.494173,"twenty":-7.759482,"median":-2.505332,"eighty":-1.945586,"marketCap":14756450},{"date":"2023-09-29","current":-1.407554,"twenty":-7.67494,"median":-2.482915,"eighty":-1.935923,"marketCap":13901004},{"date":"2023-10-06","current":-1.245144,"twenty":-7.564668,"median":-2.457093,"eighty":-1.916598,"marketCap":12297042},{"date":"2023-10-13","current":-1.320935,"twenty":-7.520559,"median":-2.4447,"eighty":-1.906934,"marketCap":13045557},{"date":"2023-10-20","current":-1.231285,"twenty":-7.45072,"median":-2.424152,"eighty":-1.895408,"marketCap":12160170},{"date":"2023-10-27","current":-1.104389,"twenty":-7.428665,"median":-2.416648,"eighty":-1.892047,"marketCap":10906941},{"date":"2023-11-03","current":-1.093561,"twenty":-7.384557,"median":-2.38986,"eighty":-1.874119,"marketCap":10800010},{"date":"2023-11-10","current":-1.11121,"twenty":-7.315269,"median":-2.385764,"eighty":-1.860896,"marketCap":10974308},{"date":"2023-11-17","current":-0.730575,"twenty":-7.201137,"median":-2.373811,"eighty":-1.857523,"marketCap":6692798},{"date":"2023-11-24","current":-0.789791,"twenty":-7.127255,"median":-2.369212,"eighty":-1.848457,"marketCap":7235276},{"date":"2023-12-01","current":-0.747068,"twenty":-7.094174,"median":-2.357617,"eighty":-1.830181,"marketCap":6843891},{"date":"2023-12-08","current":-0.723606,"twenty":-7.086822,"median":-2.356303,"eighty":-1.821705,"marketCap":6628950},{"date":"2023-12-15","current":-1.12247,"twenty":-6.958171,"median":-2.32904,"eighty":-1.802247,"marketCap":10282946},{"date":"2023-12-22","current":-0.99185,"twenty":-6.75233,"median":-2.316878,"eighty":-1.784903,"marketCap":9086334},{"date":"2023-12-29","current":-1.715922,"twenty":-6.708221,"median":-2.316878,"eighty":-1.772556,"marketCap":15719562},{"date":"2024-01-05","current":-2.042764,"twenty":-6.697194,"median":-2.312997,"eighty":-1.772556,"marketCap":18713765},{"date":"2024-01-12","current":-1.319042,"twenty":-6.65676,"median":-2.307964,"eighty":-1.77187,"marketCap":12083745},{"date":"2024-01-19","current":-1.225659,"twenty":-6.634706,"median":-2.305792,"eighty":-1.762183,"marketCap":11228259},{"date":"2024-01-26","current":-1.237332,"twenty":-6.627355,"median":-2.293705,"eighty":-1.754072,"marketCap":11335194},{"date":"2024-02-02","current":-2.700107,"twenty":-6.616328,"median":-2.29746,"eighty":-1.754029,"marketCap":24735681},{"date":"2024-02-09","current":-2.847235,"twenty":-6.601625,"median":-2.305792,"eighty":-1.754072,"marketCap":26083523},{"date":"2024-02-16","current":-2.589899,"twenty":-6.561191,"median":-2.308695,"eighty":-1.754199,"marketCap":23726061},{"date":"2024-02-23","current":-2.498058,"twenty":-6.531785,"median":-2.314752,"eighty":-1.75507,"marketCap":22884711},{"date":"2024-03-01","current":-3.159309,"twenty":-6.480325,"median":-2.316878,"eighty":-1.758262,"marketCap":28942429},{"date":"2024-03-08","current":-3.214413,"twenty":-6.30389,"median":-2.32904,"eighty":-1.76038,"marketCap":29447239},{"date":"2024-03-15","current":-2.424586,"twenty":-6.300214,"median":-2.356303,"eighty":-1.767684,"marketCap":22211632},{"date":"2024-03-22","current":-2.700107,"twenty":-6.281835,"median":-2.357617,"eighty":-1.768604,"marketCap":24735681},{"date":"2024-03-28","current":-2.534794,"twenty":-6.267132,"median":-2.366602,"eighty":-1.770841,"marketCap":23221251},{"date":"2024-04-05","current":-1.973455,"twenty":-6.248754,"median":-2.362109,"eighty":-1.772556,"marketCap":20192392},{"date":"2024-04-12","current":-2.126379,"twenty":-6.211996,"median":-2.356763,"eighty":-1.772556,"marketCap":21757107},{"date":"2024-04-19","current":-2.840964,"twenty":-6.193618,"median":-2.356891,"eighty":-1.772556,"marketCap":29068743},{"date":"2024-04-26","current":-2.832222,"twenty":-6.175239,"median":-2.366602,"eighty":-1.776613,"marketCap":28979294},{"date":"2024-05-03","current":-2.972663,"twenty":-6.175239,"median":-2.371823,"eighty":-1.797338,"marketCap":30416284},{"date":"2024-05-10","current":-3.148214,"twenty":-6.138482,"median":-2.383473,"eighty":-1.8013,"marketCap":32212521},{"date":"2024-05-17","current":-4.343518,"twenty":-6.120103,"median":-2.387022,"eighty":-1.8013,"marketCap":34969664},{"date":"2024-05-24","current":-4.016267,"twenty":-6.101724,"median":-2.38986,"eighty":-1.8013,"marketCap":32334963},{"date":"2024-05-31","current":-3.480765,"twenty":-6.101724,"median":-2.406218,"eighty":-1.803194,"marketCap":28023635},{"date":"2024-06-07","current":-3.123763,"twenty":-6.072318,"median":-2.424369,"eighty":-1.803668,"marketCap":25149416},{"date":"2024-06-14","current":-3.123763,"twenty":-6.009831,"median":-2.429769,"eighty":-1.813745,"marketCap":25149416},{"date":"2024-06-21","current":-3.867516,"twenty":-5.951019,"median":-2.442232,"eighty":-1.82096,"marketCap":31137372},{"date":"2024-06-28","current":-3.451014,"twenty":-5.928964,"median":-2.442954,"eighty":-1.821457,"marketCap":27784117},{"date":"2024-07-05","current":-3.332014,"twenty":-5.90691,"median":-2.450362,"eighty":-1.821705,"marketCap":26826044},{"date":"2024-07-12","current":-3.480765,"twenty":-5.899559,"median":-2.461322,"eighty":-1.82441,"marketCap":28023635},{"date":"2024-07-15","current":-3.841633,"twenty":-5.899559,"median":-2.463437,"eighty":-1.825312,"marketCap":30928991},{"date":"2024-08-02","current":-3.659265,"twenty":-5.899559,"median":-2.465551,"eighty":-1.826214,"marketCap":29460744},{"date":"2024-08-09","current":-3.451014,"twenty":-5.862801,"median":-2.495981,"eighty":-1.82982,"marketCap":27784117},{"date":"2024-08-16","current":-3.277028,"twenty":-5.826044,"median":-2.500741,"eighty":-1.82982,"marketCap":26586525},{"date":"2024-08-23","current":-2.868178,"twenty":-5.789287,"median":-2.513304,"eighty":-1.830723,"marketCap":23269530},{"date":"2024-08-30","current":-3.045274,"twenty":-5.734151,"median":-2.521511,"eighty":-1.847957,"marketCap":24706310},{"date":"2024-09-06","current":-2.956577,"twenty":-5.704745,"median":-2.527177,"eighty":-1.847957,"marketCap":23986709},{"date":"2024-09-13","current":-3.163537,"twenty":-5.638581,"median":-2.534153,"eighty":-1.847957,"marketCap":25665778},{"date":"2024-09-20","current":-2.909272,"twenty":-5.609176,"median":-2.534794,"eighty":-1.848957,"marketCap":23602921},{"date":"2024-09-27","current":-3.060057,"twenty":-5.6055,"median":-2.550655,"eighty":-1.849282,"marketCap":24826243},{"date":"2024-10-04","current":-3.045274,"twenty":-5.6055,"median":-2.558322,"eighty":-1.855371,"marketCap":24706310},{"date":"2024-10-11","current":-2.94209,"twenty":-5.576094,"median":-2.581328,"eighty":-1.857735,"marketCap":23869174},{"date":"2024-10-18","current":-2.956577,"twenty":-5.568742,"median":-2.589899,"eighty":-1.857946,"marketCap":23986709},{"date":"2024-10-25","current":-2.749617,"twenty":-5.524633,"median":-2.6017,"eighty":-1.857946,"marketCap":22307639},{"date":"2024-10-31","current":-2.956577,"twenty":-5.469498,"median":-2.624687,"eighty":-1.858451,"marketCap":23986709},{"date":"2024-11-08","current":-3.144911,"twenty":-5.429065,"median":-2.630686,"eighty":-1.860896,"marketCap":25514662},{"date":"2024-11-15","current":-2.853379,"twenty":-5.421713,"median":-2.652961,"eighty":-1.862302,"marketCap":26145512},{"date":"2024-11-22","current":-3.167774,"twenty":-5.333495,"median":-2.669956,"eighty":-1.862302,"marketCap":29026316},{"date":"2024-11-29","current":-3.324579,"twenty":-5.096772,"median":-2.677956,"eighty":-1.864729,"marketCap":30463120},{"date":"2024-12-06","current":-3.612535,"twenty":-4.811505,"median":-2.691821,"eighty":-1.872202,"marketCap":33101658},{"date":"2024-12-13","current":-3.455468,"twenty":-4.783906,"median":-2.700107,"eighty":-1.878104,"marketCap":31662455},{"date":"2024-12-20","current":-3.010446,"twenty":-4.710085,"median":-2.714233,"eighty":-1.882064,"marketCap":27584715},{"date":"2024-12-27","current":-3.350757,"twenty":-4.584745,"median":-2.719152,"eighty":-1.887995,"marketCap":30702987},{"date":"2025-01-03","current":-3.560179,"twenty":-4.526311,"median":-2.72633,"eighty":-1.889342,"marketCap":32621924},{"date":"2025-01-10","current":-3.455468,"twenty":-4.511591,"median":-2.735883,"eighty":-1.892949,"marketCap":31662455},{"date":"2025-01-17","current":-3.691068,"twenty":-4.376397,"median":-2.749617,"eighty":-1.894597,"marketCap":33821259},{"date":"2025-01-24","current":-3.612535,"twenty":-4.327237,"median":-2.751576,"eighty":-1.895279,"marketCap":33101658},{"date":"2025-01-31","current":-3.531384,"twenty":-4.314599,"median":-2.779324,"eighty":-1.896985,"marketCap":32358070},{"date":"2025-02-07","current":-3.830678,"twenty":-4.286808,"median":-2.795685,"eighty":-1.897902,"marketCap":35100505},{"date":"2025-02-14","current":-2.702465,"twenty":-4.243374,"median":-2.803908,"eighty":-1.897902,"marketCap":24762685},{"date":"2025-02-21","current":-2.697957,"twenty":-4.213511,"median":-2.798354,"eighty":-1.898522,"marketCap":24721379},{"date":"2025-02-28","current":-2.619114,"twenty":-4.194062,"median":-2.787545,"eighty":-1.902349,"marketCap":23998938},{"date":"2025-03-07","current":-2.553367,"twenty":-4.18948,"median":-2.753394,"eighty":-1.907173,"marketCap":23396505},{"date":"2025-03-14","current":-3.959026,"twenty":-4.183407,"median":-2.750746,"eighty":-1.907891,"marketCap":36276557},{"date":"2025-03-21","current":-3.849571,"twenty":-4.176051,"median":-2.763158,"eighty":-1.911245,"marketCap":35273616},{"date":"2025-03-28","current":-3.959026,"twenty":-4.165017,"median":-2.787545,"eighty":-1.916277,"marketCap":36276557},{"date":"2025-04-04","current":-3.671929,"twenty":-4.160249,"median":-2.803908,"eighty":-1.916918,"marketCap":32364379},{"date":"2025-04-11","current":-3.279837,"twenty":-4.151505,"median":-2.828684,"eighty":-1.921875,"marketCap":28908480},{"date":"2025-04-17","current":-4.270837,"twenty":-4.1523,"median":-2.832222,"eighty":-1.92801,"marketCap":37643154},{"date":"2025-04-25","current":-4.187908,"twenty":-4.162633,"median":-2.832222,"eighty":-1.929949,"marketCap":36912219},{"date":"2025-05-02","current":-4.105394,"twenty":-4.1523,"median":-2.839244,"eighty":-1.935439,"marketCap":36184939},{"date":"2025-05-09","current":-4.312301,"twenty":-4.179729,"median":-2.842744,"eighty":-1.935923,"marketCap":38008622},{"date":"2025-05-16","current":-4.602552,"twenty":-4.19424,"median":-2.848984,"eighty":-1.937857,"marketCap":40566894},{"date":"2025-05-23","current":-4.42533,"twenty":-4.264347,"median":-2.853379,"eighty":-1.939236,"marketCap":44952504},{"date":"2025-05-30","current":-4.85707,"twenty":-4.270837,"median":-2.857222,"eighty":-1.94475,"marketCap":49338115},{"date":"2025-06-06","current":-5.040473,"twenty":-4.313409,"median":-2.868178,"eighty":-1.945021,"marketCap":51201124},{"date":"2025-06-13","current":-4.896459,"twenty":-4.374498,"median":-2.875122,"eighty":-1.94506,"marketCap":49738235},{"date":"2025-06-20","current":-4.968466,"twenty":-4.39523,"median":-2.888929,"eighty":-1.947289,"marketCap":50469680},{"date":"2025-06-27","current":-4.860456,"twenty":-4.470629,"median":-2.897445,"eighty":-1.947846,"marketCap":49372513},{"date":"2025-07-03","current":-4.896459,"twenty":-4.583199,"median":-2.902156,"eighty":-1.954946,"marketCap":49738235},{"date":"2025-07-11","current":-4.824453,"twenty":-4.667689,"median":-2.905735,"eighty":-1.959721,"marketCap":49006790},{"date":"2025-07-18","current":-4.680439,"twenty":-4.680439,"median":-2.909464,"eighty":-1.96241,"marketCap":47543901},{"date":"2025-07-25","current":-4.680439,"twenty":-4.680439,"median":-2.927011,"eighty":-1.968533,"marketCap":47543901},{"date":"2025-08-01","current":-4.464419,"twenty":-4.680439,"median":-2.93096,"eighty":-1.972646,"marketCap":45349567},{"date":"2025-08-08","current":-4.320405,"twenty":-4.680439,"median":-2.939436,"eighty":-1.973641,"marketCap":43886678},{"date":"2025-08-15","current":-4.464419,"twenty":-4.680439,"median":-2.94209,"eighty":-1.974516,"marketCap":45349567},{"date":"2025-08-22","current":-3.070089,"twenty":-4.667689,"median":-2.954419,"eighty":-1.976694,"marketCap":32739432},{"date":"2025-08-29","current":-3.256343,"twenty":-4.650337,"median":-2.956577,"eighty":-1.977813,"marketCap":34725639},{"date":"2025-09-05","current":-4.089329,"twenty":-4.637235,"median":-2.956577,"eighty":-1.977813,"marketCap":43608601},{"date":"2025-09-12","current":-4.261149,"twenty":-4.619233,"median":-2.956577,"eighty":-1.977813,"marketCap":45440896},{"date":"2025-09-19","current":-4.329877,"twenty":-4.608432,"median":-2.972663,"eighty":-1.981809,"marketCap":46173813},{"date":"2025-09-26","current":-4.020601,"twenty":-4.60608,"median":-2.986143,"eighty":-1.987802,"marketCap":42875684},{"date":"2025-10-03","current":-4.364242,"twenty":-4.603895,"median":-3.000334,"eighty":-1.99084,"marketCap":46540272},{"date":"2025-10-10","current":-3.84878,"twenty":-4.603895,"median":-3.015708,"eighty":-1.995667,"marketCap":41043390},{"date":"2025-10-17","current":-4.020601,"twenty":-4.601272,"median":-3.015708,"eighty":-1.996731,"marketCap":42875684},{"date":"2025-10-24","current":-3.951872,"twenty":-4.588583,"median":-3.015708,"eighty":-1.997747,"marketCap":42142766},{"date":"2025-10-31","current":-3.487957,"twenty":-4.572429,"median":-3.017315,"eighty":-1.997791,"marketCap":37195572},{"date":"2025-11-07","current":-3.318885,"twenty":-4.572429,"median":-3.030708,"eighty":-2.001268,"marketCap":35392594},{"date":"2025-11-14","current":-3.348439,"twenty":-4.571628,"median":-3.043553,"eighty":-2.007002,"marketCap":35707749}],"updateTime":1763404448905},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNXT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2573966588","title":"RenovoRx Inc publishes investor presentation highlighting RenovoCath commercialization and cancer therapy platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2573966588","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573966588?lang=en_us&edition=fundamental","pubTime":"2025-10-07 22:48","pubTimestamp":1759848501,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief on October 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nNDL3NvpXq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNXT","BK4539"],"gpt_icon":0},{"id":"2570097221","title":"RenovoRx announces first patient procedure completed in PanTheR study","url":"https://stock-news.laohu8.com/highlight/detail?id=2570097221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570097221?lang=en_us&edition=fundamental","pubTime":"2025-09-25 20:40","pubTimestamp":1758804044,"startTime":"0","endTime":"0","summary":"RenovoRx (RNXT) announced that the first registry-eligible patient procedure in its PanTheR Post-Marketing Registry Study has been successfully com...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/renovorx-announces-first-patient-procedure-completed-in-panther-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/renovorx-announces-first-patient-procedure-completed-in-panther-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2570090169","title":"RenovoRx’s PanTheR Post-Marketing Registry Study Progresses with First Clinical Procedure and Addition of Two Participating Clinical Sites","url":"https://stock-news.laohu8.com/highlight/detail?id=2570090169","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570090169?lang=en_us&edition=fundamental","pubTime":"2025-09-25 20:30","pubTimestamp":1758803400,"startTime":"0","endTime":"0","summary":"First Registry-Eligible Patient Procedure Commenced at the University of Vermont Cancer Center Baptist Health Miami Cancer Institute and University of Pittsburgh Medical Center Join the University of ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/25/3156272/0/en/RenovoRx-s-PanTheR-Post-Marketing-Registry-Study-Progresses-with-First-Clinical-Procedure-and-Addition-of-Two-Participating-Clinical-Sites.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","POST","BK4539","BK4139","BK4212"],"gpt_icon":0},{"id":"2566991139","title":"RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16th","url":"https://stock-news.laohu8.com/highlight/detail?id=2566991139","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566991139?lang=en_us&edition=fundamental","pubTime":"2025-09-11 20:30","pubTimestamp":1757593800,"startTime":"0","endTime":"0","summary":"MOUNTAIN VIEW, Calif., Sept.  11, 2025  (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing innovative targeted oncology therapies and c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/11/3148530/0/en/RenovoRx-CEO-Shaun-Bagai-to-Present-at-iAccess-Alpha-Virtual-Best-Ideas-Fall-Investment-Conference-2025-on-September-16th.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNXT"],"gpt_icon":0},{"id":"2564336475","title":"RenovoRx Inc. Unveils Investor Presentation Highlighting TAMP Therapy Platform and Progress in Pancreatic Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2564336475","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564336475?lang=en_us&edition=fundamental","pubTime":"2025-09-03 06:29","pubTimestamp":1756852143,"startTime":"0","endTime":"0","summary":"RenovoRx Inc., a NASDAQ-listed company, has shared insights from its recent investor presentation. The company is advancing its proprietary Trans-Arterial Micro-Perfusion  platform, which combines RenovoCath with Gemcitabine for treating pancreatic and bile duct cancers. This combination has received FDA Orphan Drug Designation. RenovoRx has initiated the commercialization of its FDA-cleared RenovoCath device, with revenues in the first half of 2025 exceeding expectations. Currently, four cancer centers are using the device, with more than 20 potential customers in discussions. The ongoing Phase III TIGeR-PaC study for locally advanced pancreatic cancer has shown promising results, with a significant reduction in adverse effects. The study's enrollment is expected to conclude by late 2025 or early 2026. RenovoRx aims to pursue a potential peak annual U.S. revenue opportunity of approximately $400 million for RenovoCath as a stand-alone device, with plans to expand its applications furt","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250902:nNDL47kNN4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2563698510","title":"RenovoRx Inc. Unveils Investor Presentation Highlighting Innovative Cancer Treatment Platform and Commercial Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2563698510","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563698510?lang=en_us&edition=fundamental","pubTime":"2025-08-29 04:25","pubTimestamp":1756412717,"startTime":"0","endTime":"0","summary":"RenovoRx Inc., a company listed on NASDAQ under the ticker symbol RNXT, has released an investor presentation detailing its latest advancements. The company is developing combination therapies utilizing its proprietary Trans-Arterial Micro-Perfusion  platform. This includes the RenovoCath device, which has received FDA Orphan Drug Designation for its combination with the drug Gemcitabine in treating pancreatic and bile duct cancers. RenovoRx has initiated the commercialization of the FDA-cleared RenovoCath, with revenues in the first half of 2025 surpassing expectations. The company is advancing a pivotal Phase III TIGeR-PaC study for treating locally advanced pancreatic cancer, observing increased overall survival and progression-free survival, and a 65% reduction in adverse effects in the first interim analysis. The study's completion is anticipated by late 2025 or early 2026. RenovoRx is pursuing a potential peak annual U.S. revenue opportunity of approximately $400 million for Reno","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250828:nNDL9hs9Hf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4539","BK4139"],"gpt_icon":0},{"id":"2562071268","title":"RenovoRx Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2562071268","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562071268?lang=en_us&edition=fundamental","pubTime":"2025-08-27 18:12","pubTimestamp":1756289520,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNXT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 27, 2025 06:12 ET (10:12 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"gpt_icon":0},{"id":"2562782939","title":"Shaun Bagai, CEO, Reports Acquisition of RenovoRx Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2562782939","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562782939?lang=en_us&edition=fundamental","pubTime":"2025-08-26 18:10","pubTimestamp":1756203042,"startTime":"0","endTime":"0","summary":"Shaun Bagai, the Chief Executive Officer and Director of RenovoRx Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 26, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nNDLbXDB5C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Shaun Bagai, CEO, Reports Acquisition of RenovoRx Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2559996126","title":"RenovoRx Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $422.00K Beat $329.67K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2559996126","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559996126?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:12","pubTimestamp":1755202372,"startTime":"0","endTime":"0","summary":"RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 8.05 percent. This is a 20 percent increase over losses of $(0.10) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/08/47138426/renovorx-q2-eps-0-08-beats-0-09-estimate-sales-422-00k-beat-329-67k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"RenovoRx Q2 EPS $(0.08) Beats $(0.09) Estimate, Sales $422.00K Beat $329.67K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"gpt_icon":0},{"id":"2559961222","title":"RenovoRx Inc. Reports Q2 2025 Revenue of Over $400,000, Marking Significant Commercial Growth for RenovoCath Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961222","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961222?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:10","pubTimestamp":1755202200,"startTime":"0","endTime":"0","summary":"RenovoRx Inc. has announced its financial results for the second quarter ended June 30, 2025. The company reported a revenue of over $400,000 from its RenovoCath device, highlighting strong demand for this FDA-cleared drug-delivery product. This marks a notable achievement for RenovoRx, as this revenue was generated without a dedicated sales and marketing team. The company also reported a net loss of $2.9 million for the quarter, an increase from the $2.4 million net loss recorded in the same period of the previous year. This $0.5 million increase in net loss was primarily attributed to a change in the fair value of the warrant liability amounting to $0.9 million, which was partially offset by a decrease in other losses. RenovoRx has also recently hired Phil Stocton as Senior Director of Sales and Market Development to build commercialization momentum and further expand its market presence. Additionally, the company announced a positive recommendation from an independent data monitorin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDL9BBCZG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"gpt_icon":0},{"id":"2559616749","title":"BRIEF-RenovoRx Q2 Net Income USD -2.895 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559616749","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559616749?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201946,"startTime":"0","endTime":"0","summary":"BRIEF-RenovoRx Q2 Net Income USD -2.895 Million\n\n\nAug 14 (Reuters) - RenovoRx Q2 basic EPS USD -0.08.\n\nQ2 operating expenses USD 2.948 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX6ED031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4539","BK4139"],"gpt_icon":0},{"id":"2559961412","title":"RenovoRx Inc. Expands Tumor Treatment Innovation with New Patent for TAMP Therapy Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961412","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961412?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201931,"startTime":"0","endTime":"0","summary":"RenovoRx Inc. has announced that its U.S. patent No. 12,290,564, titled \"Methods for Treating Tumors,\" became effective on May 6. This patent expands the protection of methods for drug delivery using RenovoRx's TAMP therapy platform, facilitated by RenovoCath. It covers innovative methods for treating tumors by delivering drugs locally to a region of an artery or blood vessel near the tumor, following treatment to reduce the microvasculature. The patent provides protection through November 2037.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via Business Wire  on August 14, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nNDLbvTT39:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2559961901","title":"RenovoRx Q2 Basic EPS USD -0.08","url":"https://stock-news.laohu8.com/highlight/detail?id=2559961901","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559961901?lang=en_us&edition=fundamental","pubTime":"2025-08-15 04:05","pubTimestamp":1755201901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250814:nPLX6ED031:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","RNXT","BK4139"],"gpt_icon":0},{"id":"2559624214","title":"RenovoRx Inc  expected to post a loss of 8 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2559624214","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559624214?lang=en_us&edition=fundamental","pubTime":"2025-08-13 05:00","pubTimestamp":1755032421,"startTime":"0","endTime":"0","summary":"RenovoRx Inc  expected to post a loss of8cents a share - Earnings Preview RenovoRx Inc RNXT.OQ RNXT.O is expected to  show a rise in quarterly revenue when it reports  results on August 14 for the per","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nL8N3U41ZT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"gpt_icon":0},{"id":"2557729683","title":"RenovoRx Expands U.S. Commercialization Efforts for the RenovoCath® Device with Growing Customer Demand and Key Leadership Hire","url":"https://stock-news.laohu8.com/highlight/detail?id=2557729683","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557729683?lang=en_us&edition=fundamental","pubTime":"2025-08-06 20:30","pubTimestamp":1754483400,"startTime":"0","endTime":"0","summary":"RenovoRx increases its commercial footprint to thirteen leading National Cancer Institute-designated and community centers approved to purchase RenovoCath Four active cancer center customers are curre","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/06/3128335/0/en/RenovoRx-Expands-U-S-Commercialization-Efforts-for-the-RenovoCath-Device-with-Growing-Customer-Demand-and-Key-Leadership-Hire.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4202","NCI","BK4539","BK4139","RNXT"],"gpt_icon":0},{"id":"2554771123","title":"RenovoRx Inc. Launches PanTheR Post-Marketing Registry Study to Evaluate RenovoCath's Effectiveness in Treating Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2554771123","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554771123?lang=en_us&edition=fundamental","pubTime":"2025-07-28 20:30","pubTimestamp":1753705822,"startTime":"0","endTime":"0","summary":"RenovoRx, Inc., a life sciences company specializing in targeted oncology therapies, has announced the launch of the PanTheR Post-Marketing Registry Study. This multi-center, observational study aims to evaluate the long-term safety and survival outcomes of patients with solid tumors treated using the RenovoCath device for targeted drug delivery. The study will collect real-world data across diverse cancer types and clinical environments, providing insights into the device's safety and effectiveness in a real-world setting. Patient enrollment is expected to commence before the end of September 2025. The study's results have not yet been presented and will provide valuable data to inform future clinical trial designs and treatment strategies. Each participating cancer center will purchase RenovoCath devices for use in the study from RenovoRx.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate an","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nNDL8kY4Wz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2551189356","title":"RenovoRx Inc. Announces Second Quarter 2025 Financial Results Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2551189356","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551189356?lang=en_us&edition=fundamental","pubTime":"2025-07-14 20:30","pubTimestamp":1752496224,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via Business Wire  on July 14, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDLWdrkP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"gpt_icon":0},{"id":"2546122602","title":"RenovoRx Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2546122602","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546122602?lang=en_us&edition=fundamental","pubTime":"2025-06-26 05:17","pubTimestamp":1750886265,"startTime":"0","endTime":"0","summary":"RenovoRx Inc. conducted its annual meeting of stockholders on June 24, 2025. During the meeting, stockholders voted on several proposals. The election of directors resulted in the appointment of Shaun R. Bagai, Ramtin Agah, M.D., Kirsten Angela Macfarlane, Laurence J. Marton, M.D., Una S. Ryan, O.B.E., Ph.D., D.Sc., and Robert J. Spiegel, M.D., FACP. Additionally, the proposal to ratify the appointment of Frank, Rimerman + Co. LLP as the independent registered public accounting firm was approved. Another proposal regarding amendments to the company's plan was not approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nNDL3GXyls:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","RNXT","BK4139"],"gpt_icon":0},{"id":"2542238318","title":"Ramtin Agah, Chief Medical Officer, Reports Acquisition of RenovoRx Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2542238318","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542238318?lang=en_us&edition=fundamental","pubTime":"2025-06-09 18:04","pubTimestamp":1749463446,"startTime":"0","endTime":"0","summary":"Ramtin Agah, the Chief Medical Officer and Director of RenovoRx Inc., reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. RenovoRx Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL4gc4jL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ramtin Agah, Chief Medical Officer, Reports Acquisition of RenovoRx Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"gpt_icon":0},{"id":"2541024527","title":"RenovoRx Is Maintained at Buy by Ascendiant Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2541024527","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541024527?lang=en_us&edition=fundamental","pubTime":"2025-06-05 18:44","pubTimestamp":1749120240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNXT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2025 06:44 ET (10:44 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}